Rekvina Labs

{
  "main_header": {
    "sid": 576337,
    "name": "Rekvina Labs",
    "stock_name": "Rekvina Labs",
    "full_name": "Rekvina Labs Ltd",
    "name_url": "stocks-analysis/rekvina-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "25.25",
    "chg": 0.25,
    "chgp": "1.0%",
    "dir": 1,
    "prev_price": "25.00",
    "mcapval": "15.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526075,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "sector_id": "",
    "indexname": "India SENSEX",
    "isin": "INE092O01028",
    "curr_date": "Aug 04, 03:30 PM",
    "curr_time": "02:35 AM",
    "last_traded_at": "Aug 04, 03:30 PM IST",
    "bse_nse_vol": "1.42 k",
    "exc_status": "Active",
    "traded_date": "Aug 04, 2026",
    "traded_date_str": "2026 08 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/rekvina-labs-576337-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Rekvina Labs Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-rekvina-labs-ltd-4136520",
        "imagepath": "",
        "date": "2026-08-04 23:20:15",
        "description": "The next results date for Rekvina Labs Ltd is scheduled for 13 August 2026...."
      },
      {
        "title": "Are Rekvina Labs Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-rekvina-labs-ltd-latest-results-good-or-bad-4006942",
        "imagepath": "",
        "date": "2026-05-22 19:21:20",
        "description": "Rekvina Labs Ltd's latest financial results for Q4 FY26 indicate a complex situation characterized by both operational challenges and some signs of sequential improvement. The company reported net sales of ₹0.72 crores, which reflects a significant sequential growth of 105.71% from ₹0.35 crores in the previous quarter. This marks a notable recovery in revenue generation, as the company had previously reported zero sales in earlier quarters.\n\nDespite the increase in revenue, Rekvina Labs continues to face persistent profitability issues, reporting a net loss of ₹0.06 crores, although this represents a 50% improvement from the loss of ₹0.12 crores in Q3 FY26. The operating margin also showed some improvement, moving from -34.29% in Q3 FY26 to -8.33% in the latest quarter. This suggests that while the company is managing to grow its revenue, it still struggles to achieve positive operating cash flow.\n\nThe mark..."
      },
      {
        "title": "Rekvina Labs Q4 FY26: Losses Deepen Despite Revenue Revival in Struggling Micro-Cap Pharma",
        "link": "https://www.marketsmojo.com/news/result-analysis/rekvina-labs-q4-fy26-losses-deepen-despite-revenue-revival-in-struggling-micro-cap-pharma-4005449",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/RekvinaLabs_quaterlyResult_4005449.png",
        "date": "2026-05-22 11:47:11",
        "description": "Rekvina Labs Limited, a micro-cap pharmaceutical contract manufacturer with a market capitalisation of ₹20.00 crores, reported a net loss of ₹0.06 crores for Q4 FY26 (Mar'26), marking a 50.00% reduction in losses compared to the previous quarter's ₹0.12 crores loss. Whilst the company demonstrated sequential revenue growth of 105.71% to reach ₹0.72 crores in Q4 FY26, the persistent inability to achieve profitability and negative operating margins continue to raise serious concerns about the viability of its business model."
      },
      {
        "title": "When is the next results date for Rekvina Labs Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-rekvina-labs-ltd-3999854",
        "imagepath": "",
        "date": "2026-05-19 23:19:40",
        "description": "The next results date for Rekvina Labs Ltd is scheduled for 21 May 2026...."
      },
      {
        "title": "Rekvina Labs Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rekvina-labs-ltd-is-rated-sell-by-marketsmojo-3992618",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/RekvinaLabsLtd_mojoScore_3992618.png",
        "date": "2026-05-15 10:10:02",
        "description": "Rekvina Labs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 66,
    "sid": "576337",
    "stock_news_url": "https://www.marketsmojo.com/news/rekvina-labs-576337"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consideration Of Unaudited Financial Result For The Quarter Ended 30Th June 2026",
      "datetime": "01-Aug-2026",
      "details": "Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Unaudited Financcial Result for the Quarter ended 30th June 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Open Offer - Updates",
      "datetime": "01-Aug-2026",
      "details": "Post offer Newspaper Annoucement",
      "source": "BSE"
    },
    {
      "caption": "Post Offer Advertisement",
      "datetime": "31-Jul-2026",
      "details": "Vivro Financial Services Pvt Ltd (Manager to the Open Offer) has submitted to BSE a copy of Post Offer Advertisement in accordance with Regulation 18(12) of the Securities Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011as amended (SEBI (SAST) Regulations) with respect to the Open Offer to the Public Shareholders of Rekvina Laboratories Ltd (Target Company).",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "13 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Rekvina Labs Ltd has announced <strong>5:10</strong> stock split, ex-date: 30 Apr 14",
          "dt": "2014-04-30",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

When is the next results date for Rekvina Labs Ltd?

2026-08-04 23:20:15

The next results date for Rekvina Labs Ltd is scheduled for 13 August 2026....

Read full news article

Are Rekvina Labs Ltd latest results good or bad?

2026-05-22 19:21:20

Rekvina Labs Ltd's latest financial results for Q4 FY26 indicate a complex situation characterized by both operational challenges and some signs of sequential improvement. The company reported net sales of ₹0.72 crores, which reflects a significant sequential growth of 105.71% from ₹0.35 crores in the previous quarter. This marks a notable recovery in revenue generation, as the company had previously reported zero sales in earlier quarters. Despite the increase in revenue, Rekvina Labs continues to face persistent profitability issues, reporting a net loss of ₹0.06 crores, although this represents a 50% improvement from the loss of ₹0.12 crores in Q3 FY26. The operating margin also showed some improvement, moving from -34.29% in Q3 FY26 to -8.33% in the latest quarter. This suggests that while the company is managing to grow its revenue, it still struggles to achieve positive operating cash flow. The mark...

Read full news article

Rekvina Labs Q4 FY26: Losses Deepen Despite Revenue Revival in Struggling Micro-Cap Pharma

2026-05-22 11:47:11

Rekvina Labs Limited, a micro-cap pharmaceutical contract manufacturer with a market capitalisation of ₹20.00 crores, reported a net loss of ₹0.06 crores for Q4 FY26 (Mar'26), marking a 50.00% reduction in losses compared to the previous quarter's ₹0.12 crores loss. Whilst the company demonstrated sequential revenue growth of 105.71% to reach ₹0.72 crores in Q4 FY26, the persistent inability to achieve profitability and negative operating margins continue to raise serious concerns about the viability of its business model.

Read full news article

When is the next results date for Rekvina Labs Ltd?

2026-05-19 23:19:40

The next results date for Rekvina Labs Ltd is scheduled for 21 May 2026....

Read full news article

Rekvina Labs Ltd is Rated Sell by MarketsMOJO

2026-05-15 10:10:02

Rekvina Labs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

View All News